Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
07/1997
07/16/1997EP0783500A1 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents
07/16/1997EP0783499A1 Benzofuran derivatives as tachykinin antagonists
07/16/1997EP0783320A1 Protection of hemopoietic cells during chemotherapy or radiotherapy
07/16/1997EP0728132B1 Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives
07/16/1997EP0527798B1 Method and composition for treating thrombosis
07/16/1997CN1154705A Organic compound
07/15/1997US5648368 Fibrinogen receptor antagonists
07/15/1997US5648250 Tissue plasminogen activator
07/15/1997US5648076 Administering antigrowth factor antibodies following surgery
07/10/1997WO1997024135A1 Amidino protease inhibitors
07/10/1997WO1997024124A1 Vitronectin receptor antagonists
07/10/1997WO1997024120A1 THIENO(2,3-b)PYRAZOLO(3,4-d)PYRIDIN-3-ONES TO ENHANCE ERYTHROPOIESIS
07/10/1997WO1997024118A1 Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
07/10/1997DE19549118A1 Use of guanidine or its derivatives to inhibit activation of haemostasis
07/10/1997CA2241723A1 Thieno(2,3-b)pyrazolo(3,4-d)pyridin-3-ones to enhance erythropoiesis
07/09/1997EP0782616A1 Therapeutic grade thrombin production and products
07/09/1997EP0782451A1 Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor
07/09/1997CN1154114A New thrombin inhibitors, their preparation and use
07/09/1997CN1153784A Biotin derivatives
07/08/1997US5646173 Tricyclic pyrrole derivatives useful as 5-HT selective agents
07/08/1997US5646165 Methionine sulfone and S-substituted cysteine sulfone derivatives as enzyme inhibitors
07/08/1997US5646160 Method of treating hyperproliferative vascular disease with rapamycin and mycophenolic acid
07/08/1997US5645833 Inhibitor resistant serine proteases
07/03/1997WO1997023499A1 Prodrugs of thrombin inhibitors
07/03/1997WO1997023480A1 Novel integrin receptor antagonists
07/03/1997WO1997023462A1 Quinoline and quinazoline compounds useful in therapy
07/03/1997WO1997023212A1 ISOXAZOLINE, ISOTHIAZOLINE AND PYRAZOLINE FACTOR Xa INHIBITORS
07/03/1997WO1997016185A3 A pharmaceutical composition for the treatment of autoimmune diseases
07/03/1997CA2240439A1 Novel integrin receptor antagonists
07/03/1997CA2238737A1 Prodrugs of thrombin inhibitors
07/02/1997EP0781558A2 Pharmaceutical use of heparin cofactor II
07/02/1997EP0781556A1 Use of condensed dihydropyridines for the treatement of chronic inflammatory processes
07/02/1997EP0781550A1 Bioadhesive pharmaceutical composition for the controlled release of active agents
07/02/1997EP0781546A1 A multi-layered film preparation
07/02/1997EP0781436A1 System and method of automatically generating chemical compounds with desired properties
07/02/1997EP0781340A1 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
07/02/1997EP0781334A1 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin
07/02/1997EP0781333A1 Gene therapy for transplantation and inflammatory or thrombotic conditions
07/02/1997EP0781133A1 Fibrinogen receptor antagonists
07/02/1997EP0621871B1 A human kunitz-type protease inhibitor variant
07/02/1997CN1153057A Yunnan Baiyao aerosol and preparing method thereof
07/01/1997US5643964 Natural amino acid derivatives as metalloproteinase inhibitors
07/01/1997US5643938 Pyrazolopyridine compounds for the treatment of anemia
07/01/1997US5643922 Indole cyclohexyl platelet activating factor antagonists
07/01/1997US5643748 HU-B1.219, a novel human hematopoietin receptor
06/1997
06/26/1997WO1997022698A2 Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies
06/26/1997WO1997022618A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
06/26/1997WO1997022359A1 Combination of g-csf with a chemotherapeutic agent for stem cell mobilisation
06/26/1997WO1997022347A1 Potentiation of complement and coagulation inhibitory properties of c1-inhibitor.
06/26/1997DE19608753C1 Transduction system based on rep-negative adeno-associated virus vector
06/26/1997DE19549232A1 Verwendung von G-CSF in Kombination mit einem Chemotherapeutikum zur Herstellung eines pharmazeutischen Präparates zur verstärkten Mobilisierung hämatopoetischer Stammzellen Use of G-CSF in combination with a chemotherapeutic agent for the preparation of a pharmaceutical composition for enhanced mobilization of hematopoietic stem cells
06/26/1997CA2240489A1 Inhibitors of interleukin-1.beta. converting enzyme
06/25/1997EP0779888A1 Pyrimido [5,4-d]pyrimidines, drugs containing these compounds, their use, and process for preparing them
06/25/1997EP0779814A1 Antithrombotic and non-hemorrhagic heparin-based compositions, method for their preparation and therapeutic applications
06/25/1997EP0706376B1 Anti-angiogenic compositions and methods of use
06/25/1997EP0696199A4 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes
06/25/1997EP0636141B1 Pyrimidinyl acetamides as elastase inhibitors
06/25/1997CN1152875A Enhanced virus-mediated DNA transfer
06/24/1997US5641810 Use of α, ω-dicarboxylic acids as fibrinogen sinkers
06/24/1997US5641777 Neurokinin receptor antagonist
06/24/1997US5641657 DNA encoding an interleukin-6 splice variant
06/19/1997WO1997021725A1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties
06/19/1997WO1997021710A1 Use of heteroaromatic and tricyclic 1,4-dihydro-1,4-dioxo-naphthalene derivatives, resulting novel compounds and therapeutical use thereof
06/19/1997WO1997021690A1 D-amino acid derived inhibitors of cysteine and serine proteases
06/19/1997WO1997021437A1 Naphthyl-substituted benzimidazole derivatives as anticoagulants
06/19/1997WO1996040098A3 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
06/19/1997CA2239908A1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties
06/19/1997CA2238175A1 D-amino acid derived inhibitors of cysteine and serine proteases
06/18/1997EP0778851A1 Method for controlling o-desulfation of heparin and compositions produced thereby
06/18/1997EP0778839A1 Novel phosphane oxides, method of preparing them and drugs containing these compounds
06/18/1997EP0778836A1 Substituted 9-alkyladenines
06/18/1997EP0778834A1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
06/18/1997EP0778829A1 Novel 4-aminopyridazines, method of preparing them and drugs containing these compounds
06/18/1997EP0778767A2 Delivery of solid drug compositions
06/18/1997EP0731812A4 POLY-beta-1-4-N-ACETYLGLUCOSAMINE
06/18/1997CN1152254A Therapeutic food composition and method to diminish blood sugar fluctuations
06/18/1997CN1151882A Mailetong capsule for promoting blood circulation
06/17/1997US5639783 Ketone derivatives
06/17/1997US5639756 Antidiabetic agents
06/17/1997US5639727 Therapeutic uses of bactericidal/permeability increasing protein products
06/17/1997US5639638 DNA molecules encoding bone morpogenetic protein-11
06/17/1997US5639469 Transmucosal delivery system
06/17/1997US5639453 Therapeutic uses of IL-3
06/17/1997US5639275 Capsule containing genetically engineered cells
06/12/1997WO1997020845A1 Pyrroloazepine derivatives
06/12/1997CA2212092A1 Pyrroloazepine derivatives
06/11/1997EP0777740A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
06/11/1997EP0777739A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
06/11/1997EP0777667A1 Cyclic benzazepine urea derivatives with aggregation-inhibiting effect
06/11/1997EP0777661A1 Natriuretic and anti-hypertensive compounds
06/11/1997EP0777657A1 Bicyclic compounds
06/11/1997EP0777649A1 N- 2-(pyrrolidinyl-1)-1-phenylethyl]acetamides as kappa receptor antagonists
06/11/1997CN1151406A Method for purifying thrombomodulin
06/11/1997CN1151403A Crystals of piperidine derivatives, intermediates for production of same, and process for producing the same
06/11/1997CN1151399A Novel hydroxylpyridinones
06/10/1997US5637599 Arginine mimic derivatives as enzyme inhibitors
06/10/1997US5637577 Treatment of potozoal diseases
06/10/1997US5637492 Activatable fibrinolytic and anti-thrombotic proteins
06/05/1997WO1997019956A1 Method for control of functionality during cross-linking of hemoglobins
06/05/1997WO1997019947A1 2'-[[4'-HALO-[1,1'-BIPHENYL]-4-YL]METHYL]-5'-METHYL-SPIRO[CYCLOPENTANE-1,7'(8'H)-[3H]IMIDAZO[2,1-b]PURIN]-4'(5'H)-ONES